Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
As per the CRISIL Ra ng framework, the score between 61-70 is considered as ‘strong'.
Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1009, up 2.04% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.49% on the day, quoting at 24991.1. The Sensex is at 81715.66, up 0.5%. Zydus Lifesciences Ltd has risen around 2.95% in last one month.
Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has risen around 1.85% in last one month and is currently quoting at 22265, up 0.34% on the day. The volume in the stock stood at 8.33 lakh shares today, compared to the daily average of 8.31 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 1018.05, up 2.71% on the day. Zydus Lifesciences Ltd is down 8.97% in last one year as compared to a 0.08% drop in NIFTY and a 0.95% drop in the Nifty Pharma index.
The PE of the stock is 22.32 based on TTM earnings ending June 25.
The company clarified that none of the observations were related to data integrity. Zydus added that it will work closely with the USFDA to address and resolve the observations expeditiously.
In a separate filing, the company also informed that the USFDA conducted a Pre-Approval Inspection (PAI) at its formulation manufacturing facility located in SEZ – II, Ahmedabad. The inspection, which covered three products and general current Good Manufacturing Practices (cGMP), was conducted from 11 August to 13 August 2025. This inspection concluded with no observations, indicating a clean outcome.
Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.
The company’s consolidated net profit shed 1% to Rs 1,170.90 crore on a 17.21% rise in revenue from operations to Rs 6,290.2 crore in Q4 FY25 over Q4 FY24.
The counter added 1.35% to end at Rs 1,002.40 on the BSE.
Zydus Lifesciences Ltd is up for a third straight session today. The stock is quoting at Rs 993.05, up 3.91% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.56% on the day, quoting at 24624.55. The Sensex is at 80559.71, up 0.4%. Zydus Lifesciences Ltd has gained around 2.54% in last one month.
Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 1.12% in last one month and is currently quoting at 21753.5, up 1.87% on the day. The volume in the stock stood at 10.56 lakh shares today, compared to the daily average of 8.49 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 993.85, up 3.82% on the day. Zydus Lifesciences Ltd is down 15.16% in last one year as compared to a 1.99% jump in NIFTY and a 0.67% jump in the Nifty Pharma index.
The PE of the stock is 16.74 based on TTM earnings ending March 25.